Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000244075 | SCV000319891 | likely benign | Cardiovascular phenotype | 2019-03-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000489388 | SCV000577126 | likely benign | not provided | 2023-02-14 | criteria provided, single submitter | clinical testing | Reported in a patient with limb anomalies consistent with Holt-Oram syndrome, but the authors were unsure whether p.(R279Q) contributed to the individual's phenotype (Debeer et al., 2007).; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 17534187) |
Labcorp Genetics |
RCV001083368 | SCV001003038 | likely benign | Aortic valve disease 2 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293126 | SCV001434116 | likely benign | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Prevention |
RCV003909886 | SCV004722076 | likely benign | TBX5-related disorder | 2019-07-30 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |